Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Retained Earnings: 2023-2025

Historic Retained Earnings for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to -$251.9 million.

  • Camp4 Therapeutics' Retained Earnings fell 26.90% to -$251.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.9 million, marking a year-over-year decrease of 26.90%. This contributed to the annual value of -$211.8 million for FY2024, which is 32.38% down from last year.
  • Camp4 Therapeutics' Retained Earnings amounted to -$251.9 million in Q3 2025, which was down 6.38% from -$236.8 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Retained Earnings peaked at -$160.0 million during Q4 2023, and registered a low of -$251.9 million during Q3 2025.
  • For the 3-year period, Camp4 Therapeutics' Retained Earnings averaged around -$213.9 million, with its median value being -$218.0 million (2024).
  • Data for Camp4 Therapeutics' Retained Earnings shows a maximum YoY slumped of 32.38% (in 2024) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Retained Earnings (Quarterly) stood at -$160.0 million in 2023, then slumped by 32.38% to -$211.8 million in 2024, then fell by 26.90% to -$251.9 million in 2025.
  • Its Retained Earnings stands at -$251.9 million for Q3 2025, versus -$236.8 million for Q2 2025 and -$224.2 million for Q1 2025.